Rethinking the way we manage medications. Using pharmacists in community family practice;Repenser notre façon de gérer les médicaments. Recourir aux pharmaciens dans la pratique familiale communautaire

Canadian Family Physician

Volumn 49, Issue SEPT., 2003, Pages 1066-1068

  Koshman, Sheri ^a   Pottie, Kevin ^b   Viner, Gary ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; COMPUTER; EDITORIAL; EDUCATION PROGRAM; ELECTRONIC MEDICAL RECORD; FAMILY MEDICINE; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE DELIVERY; HEALTH SERVICE; HUMAN; MEDICAL EDUCATION; MEDICAL SCHOOL; PATIENT CARE; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; PROFESSIONAL PRACTICE;

CANADA; DISEASE MANAGEMENT; DRUG THERAPY; FAMILY PRACTICE; HUMANS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; PHARMACIES; PHARMACISTS; PHYSICIAN'S PRACTICE PATTERNS;

EID: 0141428852     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (29)

1. William AP, Cockerill R. Report on the 1989 survey of the prescribing experiences and attitudes toward prescription drugs of Ontario physicians [Prepared for the Pharmaceutical Inquiry of Ontario]. Toronto, Ont: Government of Ontario; 1989.
2. Hohl CM, Dankoff J, Calacone A, Afilalo M. Polypharmacy. Adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 2001;38(6):666-71.
3. Tafreshi MJ, Melby MJ, Kaback KR, Nord TC. Medication-related visits to the emergency department: a prospective study. Ann Pharmacother 1999;33:1252-7.
4. Lowy F. Report of the pharmaceutical inquiry of Ontario: dispensing/administration. Toronto, Ont: Government of Ontario; 1990. pp. 119-39.
5. Canadian Medical Association and Canadian Pharmaceutical Association Joint Statement. Approaches to enhancing the quality of drug therapy. Can Med Assoc J 1996;155:784A-C.
6. Boyko WL Jr, Yurkowski PJ, Ivey MF, Armitstead JA, Roberts BL. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm 1997;54:1591-5.
7. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-70.
8. Dupuis LL. Hospital pharmacy: an evidence-based profession. Can J Hosp Pharm 2000;35:168-9.
9. Canadian Institute for Health Information [webpage]: 2002 Apr 1. National Health Expenditure Trends, 1975-2002. Ottawa, Ont: Canadian Institute for Health Information; 2002. Available from: http://secure.cihi.ca/cihiweb/dispPage.jsp?cw_page=AR_31_E Accessed 2003 Apr 3.
10. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
11. Rodgers S, Avery AJ, Meechan D, Briant S, Geraghty M, Doran K, et al. Controlled trial of pharmacist intervention in general practice: the effect on prescribing costs. Br J Gen Pract 1999;49:717-20.
12. Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001;323:1340-3.
13. Bond C, Matheson C, Williams P, Donnan P. Repeat prescribing: a role for community pharmacists in controlling and monitoring repeat prescriptions. Br J Gen Pract 2000;50:271-5.
14. Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996;100(4):428-37.
15. Blakey SA, Hixson-Wallace JA. Clinical and economic effects of pharmacy services in geriatric ambulatory clinic. Pharmacotherapy 2000;20(10):1198-203.
16. Jameson J, VanNoord G, Vanderwoud K. The impact of pharmacotherapy consultation on the cost and outcome of medical therapy. J Fam Pract 1995;41(5):469-72.
17. Cowper PA, Weinberger M, Hanlon JT, Landsman PB, Samsa GP, Uttech KM, et al. The cost-effectiveness of a clinical pharmacist intervention among elderly out-patients. Pharmacotherapy 1998;18(2):327-32.
18. Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health Syst Pharm 1997;54:554-8.
19. Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost of illness model. Arch Intern Med 1995;155:1949-56.
20. Loh EA, Warususzynski B, Poston J. Cost savings associated with community pharmacist interventions in Canada. Can Pharm J 1996;129(1):43-55.
21. Sellors J, Kaczorowski J, Woodward C, Willan A, Sellors C, Dolovich L, et al. Randomized trial evaluating expanded role pharmacists in seniors covered by provincial drug plan in Ontario. In: Health Transition Fund Report. Ottawa, Ont: Health Canada; 2000. Available from: http://www.hc-sc.gc.ca/htf-fass/english. Accessed 2003 May 10.
22. Sellors J, Sellors C, Woodward C, Dolovich L, Poston J. Expanded role pharmacists consulting in family physicians' offices - a highly acceptable program model. Can Pharm J 2001;134(7):27-31.
23. Hindmarsh W, Kaczorowski J, Lavack L, Trim K, Hardcastle L. Pharmacists and family doctors: partners in primary care pharmacotherapy. Can Pharm J 2001;134(7):33-5.
24. American College of Physicians, American Society of Internal Medicine. Pharmacist scope of practice. Ann Intern Med 2002;136:79-85.
25. Dong BJ, Echaves SA, Brody RV, Shapiro DW. Pharmacist provision of preventive health care services in a hypertension clinic. Am J Health Syst Pharm 1997;54:564-6.
26. Ellis SL, Carter BL, Malone DC, Billups SJ, Okano GJ, Valuck RJ, et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of managed pharmaceutical care on resource utilization and outcomes in Veterans Affairs Medical Centers. Pharmacotherapy 2000;20(12):1508-16.
27. Simpson SH, Johnson JJ, Tsuyuki RT. Economic impact of community pharmacist intervention in cholesterol risk management: an evaluation of the study of cardiovascular risk intervention by pharmacists. Pharmacotherapy 2001;21(5):627-35.
28. Herborg H, Soendergaard B, Froekjaer B, Fonnesbaek L, Jorgensen T, Hepler CD, et al. Improving drug therapy for patients with asthma-part 1: patient outcomes. J Am Pharm Assoc 2001;41:539-50.
29. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med 1999;159:1939-45.